Latest News

Slow-wave sleep linked to Parkinson’s disease cognition

Key clinical point: Your PD patients will do better during the day if you help them sleep better at night.

Major finding: Thirteen patients in the low SW group (81%) met criteria for mild Parkinson’s disease (PD) cognitive impairment versus seven (44%) in the higher SW sleep group.

Data source: Cognitive testing of 32 patients with PD stratified by amount of SW sleep

Disclosures: The work was funded by the National Institutes of Health. The presenter had no relevant disclosures.


 

AT ANA 2017

– Slow-wave sleep improves cognition in Parkinson’s disease, according to University of Alabama at Birmingham investigators.

After sleep studies, they compared the cognitive performance of 16 patients who spent more than 14% of their sleep time in slow-wave (SW) sleep with the cognitive performance of 16 who spent less than 14% in SW sleep; 13 of the patients in the low SW group (81%) met the criteria for mild Parkinson’s disease (PD) cognitive impairment versus 7 of the patients in the higher SW sleep group (44%); the patients were well matched for age, sex, disease duration, and other variables.

©Wavebreakmedia Ltd/Thinkstock
The finding, presented at the annual meeting of the American Neurological Association, is not entirely surprising: SW sleep is thought to influence neuroplasticity and brain repair. “It may be important for memory consolidation; people tend to learn better if they’ve had more SW sleep,” and they do better on tests the next day. The study “suggests that interventions to improve sleep might also improve cognitive function in individuals with PD,” said lead investigator and neurologist Amy Amara, MD, PhD, a PD clinician and researcher at the university.

The normative value for SW sleep is about 15%-20%, although people spend less time in SW sleep as they age. The study subjects were in their mid-60s on average, so the 14% cut point wasn’t too far off from what might be considered typical.

More SW sleep in PD was associated with better performance on measures of global function, attention/working memory, executive function, and language comprehension. Patients in the low SW group, for instance, performed 0.25 standard deviations below the normative mean on attention/working memory tests, while subjects in the high SW group performed 0.5 standard deviations above, meaning that they outperformed people in their age group who didn’t have PD. These differences were statistically significant.

It raises the question of what can be done to help PD patients sleep better. “I’m interested in exercise to improve sleep, and we have some primary data that show it’s helpful for sleep in general but also SW sleep,” said Dr. Amara. Sodium oxybate (Xyrem) might also help, but for now, it’s a controlled substance approved only for narcolepsy. “We might have to branch out and try something novel,” she said.
Dr. Amy Amara of the University of Alabama at Birmingham
Dr. Amy Amara


The next step is to “see if we can use SW sleep to predict who might have cognitive declines and find interventions to [prevent] it,” she said.
 
 

Patients in the study had been diagnosed with PD for a mean of about 7 years. People in the high SW group were on lower amounts of levodopa equivalents, however, the investigators controlled for that, as well as for the fact that women tend to spend more time in SW sleep than men. There were no differences between the groups in measures of movement problems and of subjective scores of sleep quality and daytime sleepiness.

People with high SW sleep fell asleep sooner than did those in the low SW groups, about 9 minutes versus 20 minutes. There was no correlation between visual-spatial function and SW sleep, but visual-spatial function did correlate with the amount of time spent in rapid eye movement sleep, suggesting that dreaming might be important for visual-spatial function, Dr. Amara said.

The work was funded by the National Institutes of Health. Dr. Amara had no relevant disclosures.

   Comments ()

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge

Related Articles

Next Article:

Novel models predict Parkinson’s disease motor progression